Prostaglandin Receptor Inhibitors

TXA₂/TP

TXB₂

Prostaglandin Receptor Inhibitors, Agonists, Antagonists, Activators & Modulators

Product Name	DP	EP	FP	IP	TXA₂/TP	TXB₂	Purity
Prostaglandin E2		EP					99.85%
Prostaglandin E1		EP					99.76%
U-46619					TXA₂/TP		99.61%
Prostaglandin D2	DP						99.5%
Tranilast	DP2, IC₅₀: 0.1 mM						99.95%
PF-04418948		EP2, IC₅₀: 16 nM					99.40%
Dinoprost			FP Receptor				99.63%
ONO-AE3-208		EP4, Ki: 1.3 nM EP3, Ki: 30 nM	FP, Ki: 790 nM		TP Receptor, Ki: 2400 nM		98.97%
Treprostinil			FP Receptor, Ki: 4680 nM	IP Receptor, EC₅₀: 1.9 nM IP Receptor, Ki: 32.1 nM	TP Receptor, EC₅₀: 919 nM		99.98%
Iloprost				IP			99.57%
Latanoprost			FP Receptor				99.85%
16,16-Dimethyl prostaglandin E2		EP2 EP4					99.02%
Prostaglandin E2 (Standard)		EP
Selexipag				hIP, Ki: 260 nM			99.86%
Prostaglandin E2-d₄		EP					99.90%
Grapiprant		dog EP4, IC₅₀: 35 nM dog EP4, Ki: 24 nM					99.57%
GW627368		EP					99.95%
L-798106		EP3, Ki: 0.3 nM EP4, Ki: 916 nM EP1, Ki: >5000 nM EP2, Ki: >5000 nM					99.91%
Laropiprant	DP, Ki: 0.57 nM				TP Receptor, Ki: 2.95 nM		99.34%
L-161982		EP4					99.33%
L-902688		EP4, Ki: 0.38 nM EP4, EC₅₀: 0.6 nM					99.0%
RO1138452				Rat I₂ Receptor, IC₅₀: 7 nM Rat I₂ Receptor, pKi: 8.33			99.26%
15-keto-Prostaglandin E2		EP2 EP4					≥99.0%
TG4-155		EP2, Ki: 9.9 nM					99.91%
Ginsenoside Ro					TXA₂		99.81%
DG-041		EP3, IC₅₀: 4.6-8.1 nM					99.61%
Travoprost			FP				99.99%
Asapiprant	DP1, Ki: 0.44 nM						99.89%
Omidenepag		hEP4, IC₅₀: 5480 nM hEP2, IC₅₀: 10 nM hEP2, EC₅₀: 1.1 nM					99.86%
BW 245C	DP						99.35%
Latanoprost acid			FP				98.77%
Beraprost sodium				IP			99.57%
NP-1815-PX sodium					TP		99.51%
EP4 receptor antagonist 1		EP					99.94%
Pectolinarin		EP					99.89%
Fevipiprant	DP2, Kd: 1.14 nM						99.38%
Evatanepag		EP2					98.58%
Nedocromil	PGD2						98.75%
Timapiprant	DP						98.12%
Seratrodast					TXA₂/TP		99.59%
Carbacyclin				PGI₂ Receptor			99.37%
Ramatroban	hDP2, IC₅₀: 113 nM hDP2, IC₅₀: 33.4 μM				hTP, IC₅₀: 14 nM		99.23%
MRE-269				IP Receptor			99.14%
Ozagrel					TXA₂/TP, : 11 nM	TXB₂	99.74%
CJ-42794		EP, EC₅₀: 10 nM					98.96%
p-Hydroxycinnamic acid						TXB₂, IC₅₀: 371 μM	99.94%
Prostaglandin J2	hDP, Ki: 0.9 nM hCRTH2, Ki: 6.6 nM	hEP1, Ki: 15.678 μM hEP2, Ki: 989 nM hEP3, Ki: 319 nM hEP4, Ki: 1065 nM	hFP, Ki: 553 nM	hIP, Ki: >25 μM	hTP, Ki: 6426 nM
SC-51322		EP2, pA2: 8.1					98.93%
Rivenprost		EP4, Ki: 0.7 nM					99.0%
AZD1981	DP						99.80%
Vorbipiprant		human EP4-R, Ki: 16.6 nM					98.89%
Treprostinil sodium	DP1, EC₅₀: 0.6±0.1 nM DP1, Ki: 4.4 nM	EP2, EC₅₀: 6.2±1.2 nM EP2, Ki: 3.6 nM EP4, Ki: 826 nM EP3, Ki: 2505 nM EP1, Ki: 212 nM EP1, EC₅₀: 285 nM EP3, EC₅₀: 68.9 nM EP4, EC₅₀: 181 nM	FP Receptor, Ki: 4680 nM	IP Receptor, EC₅₀: 1.9 nM IP Receptor, Ki: 32.1 nM	TP Receptor, EC₅₀: 919 nM		99.55%
Dinoprost-d₄			FP				99.9%
Omidenepag isopropyl		EP2					98.17%
Ridogrel		EP					99.64%
MF498		EP4, Ki: 0.7 nM					99.26%
Ralinepag	hDP1, EC₅₀: 850 nM			hIP, EC₅₀: 8.5 nM rIP, EC₅₀: 530 nM			99.27%
NTP42					TXA₂		98.58%
Ozagrel hydrochloride					TXA₂/TP, : 11 nM	TXB₂	99.86%
Misoprostol acid		EP					99.9%
(+)-Cloprostenol			PGF_2α				98.06%
Picotamide					TXA₂/TP		99.76%
MF-766		EP4, Ki: 0.23 nM					99.83%
SC 51089 free base		EP1, Ki: 1.3 μM EP3, Ki: 17.5 μM	FP, Ki: 61.1 μM		TP, Ki: 11.2 μM		98.60%
Cefminox sodium				IP Receptor			99.83%
Sulprostone		EP3					≥99.0%
EP4 receptor agonist 2		EP4, EC₅₀: 0.8 nM EP2, Ki: >100000 nM EP3, Ki: 38000 nM EP4, Ki: 3.1 nM					99.0%
Taprenepag isopropyl		EP2					99.02%
L 888607	DP, Ki: 0.8 nM		FP Receptor, Ki: 10018 nM	IP Receptor, Ki: 14434 nM	TP Receptor, Ki: 283 nM		99.87%
Ebopiprant			Human FP Receptor, Ki: 1 nM Rat FP Receptor, Ki: 26 nM				98.65%
EP3 antagonist 3		EP3, pKi: 8.3					99.52%
Tafluprost acid		EP3, IC₅₀: 67 nM	Human FP Receptor, Ki: 0.4 nM Human FP Receptor, EC₅₀: 0.53 nM				99.80%
BW A868C	DP2						99.90%
L-826266		EP3					99.70%
CAY10580		EP4, Ki: 35 nM EP2, Ki: 3000 nM EP3, Ki: 2000 nM EP1, Ki: >3000 nM
17-Phenyl-ω-trinor-PGE2		EP1 EP3					99.9%
Prostaglandin D2-d₄	DP						98.81%
Ozagrel sodium					TXA₂/TP, : 11 nM	TXB₂	99.82%
Treprostinil palmitil	DP						99.62%
Dinoprost tromethamine salt			FP Receptor				98.0%
Trapidil					Thromboxane A₂		98.0%
BAY-6672 hydrochloride			FP				98.01%
EP2 receptor antagonist-1		EP2					99.84%
Epibetulinic acid		EP2, IC₅₀: 0.6 μM					98.0%
Daltroban					TXA₂		98.19%
Licarin A	DP						99.83%
PDC31			FP Receptor, Ki: ~30 nM				98.67%
BI-671800	hCRTH2, IC₅₀: 4.5 nM mCRTH2, IC₅₀: 3.7 μM						99.36%
EP4-IN-1		EP4					99.94%
L 888607 Racemate	DP1, Ki: 132 nM				TP, Ki: 17 nM		99.81%
Setipiprant	hCRTH2, IC₅₀: 6 nM hDP1, IC₅₀: 1290 nM	EP2, IC₅₀: 2600 nM					98.23%
BAY 73-1449				IP Receptor, IC₅₀: <0.1 nM			98.40%
CAY10471	CRTH2						99.9%
CAY10471 Racemate	CRTH2, Ki: 0.6 nM						99.00%
MK-7246	DP, Ki: 2.5 nM				TP, Ki: 3804 nM		99.63%
SC-19220		EP1					99.86%
Pizuglanstat	DP						99.70%
EP4 receptor antagonist 2		EP4, IC₅₀: 7.8 nM					99.01%
Carboprost			FP				99.84%
AAT-008		EP4, Ki: 0.97 nM EP4, IC₅₀: 6.1 nM					98.03%
EP2 receptor antagonist-2		EP					99.32%
Treprostinil diethanolamine	DP1, Ki: 4.4 nM	EP2, Ki: 3.6 nM EP1, Ki: 212 nM EP4, Ki: 826 nM EP3, Ki: 2505 nM	FP, Ki: 4680 nM	IP, Ki: 32.1 nM			99.44%
PGN-9856		EP2, pEC₅₀: ≥ 8.5 EP2, pKi: ≥ 8.3					98.90%
BAY-1316957		human EP4-R, IC₅₀: 15.3 nM					99.73%
PROTAC(H-PGDS)-7	DP						99.42%
KW-8232		EP					98.10%
Cloprostenol isopropyl ester			FP				98.0%
15-keto-Prostaglandin F2a			FP				99.2%
Saikogenin D		EP					99.99%
GSK-269984A		EP1, pIC₅₀: 7.9					99.58%
Ifetroban					TXA₂/TP		99.65%
Pexopiprant	DP2, Ki: <100 nM						99.40%
Aganepag isopropyl		EP					98.23%
Nedocromil sodium	DP
Tiaprost			PGF_2α				98.0%
KP496					TXA₂ Receptor		99.79%
Prostaglandin E2-d₉		EP					99.5%
BGC-20-1531 free base		EP4, pKd: 7.6
KW-8232 free base		EP
Aganepag		EP2, EC₅₀: 0.19 nM					99.71%
Taprostene				IP			98.1%
AMX12006		hEP4, IC₅₀: 4.3 nM					99.9%
Darbufelone mesylate			PGF_2α				99.65%
AMG-009	DP, IC₅₀: 12 nM CRTH2, IC₅₀: 3 nM						98.08%
Prostaglandin D2-d₉	DP						99.9%
Selexipag-d₇				IP			98.44%
TP receptor antagonist-3					hTP, IC₅₀: 15.7 nM		99.88%
SC 51089		EP1, Ki: 1.3 μM EP3, Ki: 17.5 μM	FP, Ki: 61.1 μM		TP, Ki: 11.2 μM
Carboprost tromethamine			FP				99.85%
ONO-8711		EP
Tranilast sodium	DP2, IC₅₀: 0.1 mM
Iloprost-d₄				IP
Sulotroban					TXA₂ Receptor		99.29%
HTL0039732		EP4
Sepetaprost		EP3	FP Receptor
BAY-6672			FP
Laropiprant sodium	DP, Ki: 0.57 nM				TP, Ki: 2.95 nM
MK-8318	DP, Ki: 5.0 nM
CP-432		human EP4-R, IC₅₀: 2 nM dog EP4, IC₅₀: 8 nM human EP4-R, EC₅₀: 1 nM
CCI17464		EP4
ICI 185282					TXA₂ Receptor
GSK345931A		EP1
Prostaglandin D2 methyl ester	hDP, Ki: 270 nM hCRTH2, Ki: 460 nM mCRTH2, Ki: 160 nM
Prostaglandin E1-d₉		EP
AL-6556	DP, EC₅₀: 799 nM	EP2, EC₅₀: 1180 nM
(R)-Vorbipiprant		hEP4, Ki: 16.6 nM
Dinoprost-d₉			FP
TGI-15			FP
EP1 receptor antagonist-1		EP1
Selexipag-d₆				IP
L-644698	hDP receptor, Ki: 0.9 nM	hEP2, Ki: 267 nM hEP3, Ki: 3730 nM hEP4, Ki: 9280 nM
MK-447				PGI₂
ASP7657 free base		hEP4, IC₅₀: 2.21 nM rat EP4, IC₅₀: 6.02 nM					99.30%
Nocloprost		EP1 EP3
(S)-Trimetoquinol hydrochloride					Thromboxane A₂
CGS-22652					TXA₂ Receptor
Wy 27569					TXA₂
Travoprost (Standard)			FP
I-SAP					TXA₂ Receptor
CV-6504					TXA₂ synthase
2-(E-2-decenoylamino)ethyl 2-(cyclohexylethyl) sulfide				PGI₂
Treprostinil-¹³C₂,d	DP	EP
Domitroban					Thromboxane A₂
KT2-962					TXA₂ Receptor
Prostaglandin E1 (Standard)		EP
BPN-37440		EP2, IC₅₀: 53-60 nM
EP4 receptor agonist 1		hEP4, pEC₅₀: 6.3
TG11-77 hydrochloride		EP2, Kb: 9.7 nM
EP4 receptor antagonist 8		EP4, IC₅₀: 6.4 nM
Misoprostol acid-d₅		EP
E-6700					TXA₂, IC₅₀: 0.026 μM
TP-16		EP4, IC₅₀: 2.1 nM
AGN 210676	hDP receptor, EC₅₀: 7749 nM	EP2, EC₅₀: 5 nM hEP3, EC₅₀: 153 nM
KC-764					TXA₂
(E/Z)-Ozagrel sodium					TXA₂, IC₅₀: 11 nM
CAY10535			FP Receptor		TP Receptor
Prostaglandin F2α dimethyl amine			FP
FR191413		EP2
TG6-129		EP
AM-461	DP2
AGN 225660	DP1, IC₅₀: 220 nM	EP1, IC₅₀: 70 nM EP4, IC₅₀: 70 nM	FP, IC₅₀: 180 nM		TP, IC₅₀: 5 nM
CAY10595	DP, Ki: 10 nM
CXT29					TP, IC₅₀: 96 nM
TPα/β antagonist-1					TPα, IC₅₀: 1.52 nM
Ramatroban-d₄					TXA₂/TP
Latanoprost (Standard)			FP Receptor
LCB 2853 sodium					TXA₂
EP3 antagonist 6		EP3, IC₅₀: 1.9 nM
ICI 192605					TXA₂/TP
AZ-11665362	DP2, IC₅₀: 2.6 nM
rel-Latanoprost acid			FP
PF-04475270		hEP4, IC₅₀: 2 nM dog EP4, IC₅₀: 8 nM
AGN192093					TP, EC₅₀: 1.3 nM
Etersalate					TXA₂
Terbogrel					TXA₂/TP
AZ-1355				Prostaglandin I₂	TXA₂/TP		98.19%
BM567					TXA₂ Receptor, IC₅₀: 1.1 nM TXA₂ synthase, IC₅₀: 12 nM
EP2 receptor agonist 2		EP2, EC₅₀: 13 nM hEP1, EC₅₀: >10000 nM hEP3, EC₅₀: >10000 nM hEP4, EC₅₀: >10000 nM	hFP, EC₅₀: >10000 nM	hIP, EC₅₀: >10000 nM
8-iso-15-keto Prostaglandin F2α			FP
11-Deoxy-16,16-dimethyl-PGE2		EP2 EP3
ER-819762		EP4, IC₅₀: 70 nM
ONO-8815Ly		EP2
BM-573					TXA₂, IC₅₀: 1.3 nM
Deacetyltanghinin					TXA₂
EP2 receptor agonist 4		EP2, EC₅₀: 43 nM
ONO-8539		EP1
SC-19220 (Standard)		EP1
L 657925					TXA₂
Prostaglandin A3		EP2, IC₅₀: 120 nM EP4, IC₅₀: 20 nM
Prostaglandin E1-d₄		EP
CAY10509			FP, IC₅₀: 30 nM
CRTh2 antagonist 2	DP						99.78%
Ozagrel hydrochloride (Standard)					TXA₂, IC₅₀: 11 nM
Rebamipide-d₄		EP					99.0%
CRTH2-IN-1	hDP2, IC₅₀: 6 nM hDP1, IC₅₀: 1 μM
LCB-2853					TXA₂ Receptor
RS-601					TXA₂ Receptor
CGS 15435					TXA₂, IC₅₀: 1 nM
BGC-20-1531		EP4
CI-949						TXB₂, IC₅₀: 0.1 μM
YM158 free base					TXA₂ Receptor, pA2: 8.81
Bunaprolast						TXB₂
KF 13218						TXB₂, IC₅₀: 5.3 nM

Name
Email *

	Sorry, but the email address you supplied was invalid.